P-256 Survival rates of locally advanced and metastatic pancreatic cancer in Western Australia

Pancreatic adenocarcinoma has one of the poorest survival rates, with median overall survival (OS) commonly ranging between 10 to 12 months. Lancet Oncology details that Australia, in particular Western Australia, has one of the best survival rates for pancreatic cancer globally given a 5-year net survival rate of 18.1%. This retrospective analysis:- 1. Examines overall survival rates of patients with locally advanced or metastatic pancreatic...